logo

VIVIMEDLAB vs ZOTA: Stock Comparison

VIVIMEDLAB vs ZOTA HEALTH CAREUpdated 16 Apr 26, 4:01 PM ISTNSE & company filings

ZOTA HEALTH CARE is the larger company by market capitalisation. VIVIMEDLAB shows a higher ROCE, while ZOTA HEALTH CARE shows a higher ROE, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

VIVIMEDLAB leads 1; ZOTA leads 8 of 11

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

VIVIMEDLABZOTA

Valuation lens

What price are you paying?

Market CapContext only
₹53 Cr
₹4,714 Cr
P/E RatioSame reading
—
0x
P/B RatioSame reading
—
6.8x
EPSZOTA has the higher reading
₹-17.61
₹-12.58 ✓
Book ValueContext only
—
₹201.01
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
ZOTA is the larger company
₹4,714 Cr vs ₹53 Cr
EPS
ZOTA has higher earnings per share
₹-12.58 vs ₹-17.61
Revenue Growth (TTM YoY)
ZOTA has faster revenue growth
67.7% vs -22.42%
Qtr Sales Growth
ZOTA has stronger quarterly sales growth
0% vs -24.95%
Qtr Profit Growth
ZOTA has stronger quarterly profit growth
0% vs -782.17%
ROE
ZOTA has a higher ROE
-10.64% vs -57.01%
ROCE
VIVIMEDLAB has a higher ROCE
-5.3% vs -8.71%
Net Margin
ZOTA has a higher net margin
-13.98% vs -27.09%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricVIVIMEDLABZOTA
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricVIVIMEDLABZOTA
Live Price₹7.39₹1,359.9
Day Change-3.15%-3.51%
Volume1.47 L44,643
52-Week High₹20.59₹1,740
52-Week Low₹5.15₹1,022
Distance from 52W High-64.11%-21.84%

Valuation

MetricVIVIMEDLABZOTA
Market Cap₹53 Cr₹4,714 Cr
P/E Ratio—0x
P/B Ratio—6.8x
EPS₹-17.61₹-12.58
Book Value—₹201.01
Dividend Yield0%0%

Growth

MetricVIVIMEDLABZOTA
Revenue Growth (TTM YoY)-22.42%67.7%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth-24.95%0%
Qtr Profit Growth-782.17%0%

Profitability & Leverage

MetricVIVIMEDLABZOTA
ROE-57.01%-10.64%
ROCE-5.3%-8.71%
Net Margin-27.09%-13.98%
Operating Margin-40.67%-11.6%
Debt to Equity8.29x0.04x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricVIVIMEDLABZOTA
Promoter Holding7.57%▼ 0.2 pp49.38%
FII Holding1.64%7.92%▼ 0.29 pp
DII Holding0%6.75%▲ 0.35 pp
Public Holding90.67%▲ 0.19 pp35.96%▼ 0.04 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: VIVIMEDLAB and ZOTA HEALTH CARE.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.